novo nordisk glp-1 medications Ozempic is first drug FDA-approved for kidney disease Trump low-cost GLP-1 plan a
Description
As more powerful GLP-1s, like tirzepatide (a.k.a
Orforglipron significantly reduced HbA1c to 2.1% in a phase II clinical trial assessing its use in T2DM, while dulaglutide achieved 1.1% and a placebo achieved 0.43% [106]
These prebiotic carbs feed gut microbes that produce short-chain fatty acids linked to higher GLP-1 levels
For those who cannot tolerate whey, plant-based protein blends combining pea, rice, and hemp proteins provide comparable amino acid profiles
One year later, the results speak for themselves
